Aortic valve stenosis and atrial fibrillation influence plasma fibulin-1 levels in patients treated with coronary bypass surgery

Cardiology (Switzerland)

Volumn 126, Issue 3, 2013, Pages 202-206

  Hansen, Maria Lyck ^a   Dahl, Jordi S ^b   Scott Argraves, W ^c   Irmukhamedov, Akhmadjon ^a   Rasmussen, Lars Melholt ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b Department of Cardiology ^*  (Denmark)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Aortic valve stenosis; Atrial fibrillation; Biomarkers; Cardiac fibrosis; Fibulin 1; Heart failure

Indexed keywords

CREATININE; FIBULIN 1; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; FIBULIN;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; AORTA VALVE; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; BLOOD SAMPLING; CAUSE OF DEATH; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DISEASE COURSE; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART MUSCLE FIBROSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; SMOKING; SMOKING HABIT; SUDDEN CARDIAC DEATH; TRICUSPID VALVE; DISEASE MARKER; HEART SURGERY; PREDICTIVE VALUE; TREATMENT OUTCOME;

AGED; AORTIC VALVE STENOSIS; ATRIAL FIBRILLATION; CALCIUM-BINDING PROTEINS; CAUSE OF DEATH; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; FIBROSIS; HUMANS; MALE; MYOCARDIUM; PROGNOSIS;

EID: 84888186588     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000354217     Document Type: Article

References (18)

1. Lung B, Vahanian A: Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol 2011; 8: 162-172.
2. Berk BC, Fujiwara K, Lehoux S: ECM remodeling in hypertensive heart disease. J Clin Invest 2007; 117: 568-575. (Pubitemid 46348511)
3. Creemers EE, Pinto YM: Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc Res 2011; 89: 265-272.
4. Carabello BA, Paulus WJ: Aortic stenosis. Lancet 2009; 373: 956-966.
5. Argraves SW, Tran H, Burgess WH, Dickerson K: Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure. J Cell Biol 1990; 111: 3155-3164. (Pubitemid 120034050)
6. Dahl JS, Møller JE, Videbæk L, Poulsen MK, Rudbæk TR, Pellikka PA, Argraves SW, Rasmussen LM: Plasma fibulin-1 is linked to restrictive filling of the left ventricle and to mortality in patients with aortic valve stenosis. J Am Heart Assoc 2012; 1:e003889.
7. Beisvag V, Lehre PK, Midelfart H, Aass H, Geiran O, Sandvik AK, Lægreid A, Komorowski J, Ellingsen Ø: Aetiology-specific patterns in end-stage heart failure patients identified by functional annotation and classification of microarray data. Eur J Heart Fail 2006; 8: 381-389. (Pubitemid 43832172)
8. Kruger R, Schutte R, Huisman HW, Argraves SW, Rasmussen LM, Olsen MH, Schutte AE: NT-proBNP is associated with fibulin-1 in Africans: the SAfeEIC study. Atherosclerosis 2012; 222: 216-221.
9. Cangemi C, Skov V, Poulsen MK, Funder J, Twal WO, Gall M, Hjortdal V, Jespersen ML, Kruse TA, Aagård J, Parving H, Knudsen S, Høilund-Carlsen P, Rossing P, Henriksen JE, Argraves WS, Rasmussen LM: Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetes. Clin Chem 2011; 57: 1556-1565.
10. Piscaglia F, Dudás J, Knittel T, Di Rocco P, Kobold D, Saile B, Zocco MA, Timpl R, Ramadori G: Expression of ECM proteins fibulin-1 and-2 in acute and chronic liver disease and in cultured rat liver cells. Cell Tissue Res 2009; 337: 449-462.
11. Lau JY, Oliver BG, Baraket M, Beckett EL, Hansbro NG, Moir LM, Wilton SD, Williams C, Foster PS, Hansbro PM, Black JL, Burgess JK: Fibulin-1 is increased in asthma-a novel mediator of airway remodeling? PLoS One 2010; 5:e13360.
12. Dweek MR, Boon NA, Newby DE: Calcific aortic stenosis. J Am Coll Cardiol 2012; 60: 1854-1863.
13. Pellikka PA, Sarano ME, Nishimura RA, Malouf JF, Bailey KR, Scott CG, Barnes ME, Tajik AJ: Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005; 111: 3290-3295. (Pubitemid 40875002)
14. Roark EF, Keene DR, Haudenchild CC, Godyna S, Little CD, Argraves WS: The association of human fibulin-1 with elastic fibers: an immunohistological, ultrastructural, and RNA study. J Histochem Cytochem 1995; 43: 401-411.
15. Morello A, Lloyd-Jones DM, Chae CU, van Kimmernade RR, Chen AC, Baggish AL, O'Donoghue M, Lee-Lewandrowski E, Januzzi JL Jr: Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Am Heart J 2007; 153: 90-97. (Pubitemid 44880879)
16. Corell P, Gustafsson F, Schou M, Markenvard J, Nielsen T, Hildebrandt P: Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 2007; 9: 258-265. (Pubitemid 46330140)
17. Kallel S, Jarrya A, Triki Z, Abdenadher M, Frikha J, Karoui A: The use of N-terminal pro-brain natriuretic peptide as a predictor of atrial fibrillation after cardiac surgery. J Cardiovasc Surg 2013; 54: 403-411.
18. Chan MY, Lin M, Lucas J, Moseley A, Thompson JW, Cyr D, Ueda H, Kajikawa M, Ortel TL, Becker RC: Plasma proteomics of patients with non-valvular atrial fibrillation on chronic anti-coagulation with warfarin or a direct factor Xa inhibitor. Thromb Haemost 2012; 108: 1180-1191.